Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Xerostomia 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Radiation Injuries 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Neurotoxicity Syndromes 1Multiple Myeloma 1Lung Neoplasms 1Hydatidiform Mole 1Hepatoblastoma 1Head and Neck Neoplasms 1Gestational Trophoblastic Disease 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Oxaliplatin 4Sodium Chloride 3Paclitaxel 3Carboplatin 3xaliproden 2Taxes 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Magnesium Sulfate 2Leucovorin 2Fluorouracil 2Calcium Gluconate 2neurotropin 1glutamic acid diethyl ester 1Vitamin E 1Thioctic Acid 1Temozolomide 1Saline Solution 1Radiosurgery 1Prednisolone 1Methylprednisolone 1Memantine 1Lamotrigine 1Ketamine 1Glutathione 1Glutamic Acid 1Ginkgo Extract 1Gabapentin 1Duloxetine Hydrochloride 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neurotoxicity Syndromes × Amifostine × Clear all
NCT00058071 2013-07-09

Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer

GOG Foundation

Phase 3 Completed
100 enrolled
Gynecologic

Hydatidiform Mole, Peripheral Nervous System Diseases, Neurotoxicity Syndromes, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡